Skip over navigation

Rare Cancers Europe logo

  • About Rare Cancers
    • Definition of Rare Cancers
    • "Families" and List of Rare Cancers
    • The Burden and the Challenges of Rare Cancers
    • The Added Value of Research on Rare Cancers
  • About the Campaign - Objectives
  • Call to Action
    • Full text
    • Signatories
  • Political Recommendations
  • EU initiatives
  • How to get involved
  • News
    • 21 November 2012: Joint Statement on EU Clinical Trials Regulation
    • 3 October 2012: Survey Open: Access to Rare Cancer Care in the EU – Have Your Say!
    • 20 July 2012: International survey on Pathology in Rare Cancers launched
    • 12 June 2012: U.S. NCI issues guidance for deliberations on rare cancer trial closures
    • 4 June 2012: Rare cancer research project announces world’s largest release of human cancer genome data
    • 2 April 2012: Cancer Cell Line Encyclopedia may help to improve rare cancer research
    • 27 March 2012: European Alliance for Personalised Medicine calls for early access to personalised medicine
    • 12 March 2012: ESMO Conference on Sarcoma and GIST: Doctors lack awareness of rare forgotten cancers
    • 21 February 2012: European conference explores ways to improve clinical research on rare cancers
    • 15 February 2012: International Childhood Cancer Day: Calls for policy changes
    • 24 November 2011: International Rare Cancers Initiative: EORTC – UK – US Global Collaboration
    • 16 November 2011: Recommendations on Quality Criteria for Centres of Expertise for Rare Diseases adopted by EUCERD
    • 10 November 2011: EU consultation to improve recognition of cross-border prescriptions
    • 24 September 2011: Rare Cancers Europe: New name and new action
    • 24 September 2011: European Multidisciplinary Cancer Congress highlights challenges posed by rare cancers
    • 12 July 2011: EP Workshop on Rare Cancers: The Added Value of Closer Cooperation
    • 20 May 2011: European Platform for Rare Disease Registries
    • 31 March 2011: EurocanPlatform for cross border cancer research launched
    • 22 March 2011: EU Register of Clinical Trials launched Online
    • 15 March 2011: European childhood cancer research in danger
    • 28 February 2011: Rare Disease Day – Focus on Health Inequalities
    • 15 February 2011: MEPs remember Children with Cancer
    • 12 January 2011: EP Meeting: Challenges of Rare Cancers
    • 27 November 2010: Open Letter concerning 2011 UN Summit on Non-Communicable Diseases
    • 9 October 2010: ESMO Rare Cancers Press Briefing
    • 9 October 2010: ESMO 2010 Rare Cancers Press Briefing Videos
    • 7 October 2010: Underestimated Obstacles to Rare Cancer Care
    • 5 October 2010: EP Meeting: Orphan Drugs for Rare Cancers
    • 13 September 2010: European Action Against Rare Cancers Secretariat
    • 9 December 2009: EU Committee of Experts on Rare Diseases
    • 24 June 2009: Launch of European Action Against Rare Cancers
    • 10 December 2008: Rare cancers are common; optimal care is not
  • Rare Cancers Conference 2012
  • Surveys
  • Events
  • Cooperating organisations
    • Campaign Organisation Committee
    • Governance principles
    • Video testimonials from Cooperating organisations
    • Quotes from the Cooperating organisations
  • Corporate supporters
  • Links
    • General Cancer Patient Support Organisations and Sites
    • Rare Cancer Type-Specific Patient Support Organisations and Sites
    • General Professional Organisations, Research Organisations and Sites
    • Cancer Type-Specific Professional Organisations, Research Initiatives and Sites
    • Clinical Practice Guidelines for Professionals and Guides for Patients
  • Campaign materials
  • Contact us

"Families" and List of Rare Cancers

Rare cancers can be grouped into the following "families":

  • Rare SKIN cancers and NON-CUTANEOUS MELANOMA
  • Rare THORACIC cancers (mesothelioma, thymoma, rare lung cancers, rare breast cancers)
  • Rare UROGENITAL cancers (kidney cancers, bladder cancers, urinary tract cancers)
  • Rare FEMALE GENITAL cancers (cervical and ovarian cancers)
  • Rare MALE GENITAL cancers (prostate and testicular cancers)
  • NEUROENDOCRINE cancers
  • ENDOCRINE ORGAN cancers (adrenal cancer, thyroid and parathyroid cancer)
  • Rare CNS cancers (brain cancer)
  • SARCOMAS
  • Rare DIGESTIVE cancers (oesophageal cancers, stomach and small intestine cancer, colorectal and anal cancers, liver cancers, gallbladder cancers and cancers of the Intrahepatic/Extrahepatic Bile Tract (IBT/EBT), pancreatic cancers)
  • Rare cancers of HEAD & NECK
  • Rare HAEMATOLOGIC cancers (lymphomas, leukaemias, myelodysplastic and myeloproliferative disorders/neoplasms)
  • PAEDIATRIC solid cancers

For a graph illustrating the distribution of families of rare cancers within all rare cancers, click here (graph courtesy of the RARECARE project).

A list of rare cancers has been provided by the RARECARE project, based on the International Classification of Diseases for Oncology (ICD-O 3rd edition). The list of rare cancers can be downloaded from the RARECARE Web site.

A presentation on the development of the list of rare cancers can be downloaded here.


Further reading:

  • GENERAL, Europe: Rare cancers are not so rare: The rare cancer burden in Europe (November 2011, European Journal of Cancer Vol. 47, Issue 17, Pages 2493-2511); free download
  • GENERAL, United States: The Occurrence of Rare Cancers in U.S. Adults, 1995-2004 (January-February 2010, Public Health Reports Vol. 125(1), Pages 28-43); free download
  • SKIN / MELANOMA: Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe (May 2012, European Journal of Cancer Vol. 48, Issue 8, Pages 1167-1175); abstract
  • THORACIC: Rare thoracic cancers, including peritoneum mesothelioma (May 2012, European Journal of Cancer Vol. 48, Issue 7, Pages 949-960); free download
  • UROGENITAL: Incidence and survival of rare urogenital cancers in Europe (March 2012, European Journal of Cancer Vol. 48, Issue 4, Pages 456-464); abstract
  • MALE GENITAL: Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe (January 2012, European Journal of Cancer Vol. 48, Issue 2, Pages 159-169); abstract
  • ENDOCRINE: Carcinoma of endocrine organs: Results of the RARECARE project (September 2012, European Journal of Cancer, Volume 48, Issue 13 , Pages 1923-1931); free download
  • CNS: Epidemiology of glial and non-glial brain tumours in Europe (July 2012, European Journal of Cancer Vol. 48, Issue 10, Pages 1532-1542); abstract
  • SARCOMAS: Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project (18 October 2012, European Journal of Cancer, In Press Corrected Proof); abstract
  • DIGESTIVE: Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002 (July 2012, European Journal of Cancer Vol. 48, Issue 10, Pages 1417-1424); abstract
  • HEAD & NECK: Rare cancers of the head and neck area in Europe (April 2012, European Journal of Cancer Vol. 48, Issue 6, Pages 783-796); free download
  • HAEMATOLOGIC: Incidence, survival and prevalence of myeloid malignancies in Europe (November 2012, European Journal of Cancer Vol. 48, Issue 17, Pages 3257-3266); abstract
  • HAEMATOLOGIC: Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project (November 11, 2010, Blood Vol. 116, no. 19, Pages 3724-3734); free download
  • EMBRYONAL: Embryonal cancers in Europe (July 2012, European Journal of Cancer Vol. 48, Issue 10, Pages 1425-1433); abstract
  • PAEDIATRIC: Survival of European children and young adults with cancer diagnosed 1995–2002 (April 2009, European Journal of Cancer Vol. 45, Issue 6, Pages 992-1005); abstract
200. Call to Action

© Rare Cancers Europe 2012. All rights reserved.
We welcome requests for permission to reprint or translate the information on this website, including the Call to Action Against Rare Cancers, for non-commercial use. However, the content, layout and logo of the website may not be copied without attribution to the campaign, and no modifications of the content, layout or logo are permitted. The cooperating organisations behind this campaign have made every effort to provide accurate information on this website. However, the cooperating organisations and corporate supporters accept no liability for any inaccuracies or omissions, nor can they accept liability for any loss or damage resulting from any inaccuracy in this information or third party information such as details on websites to which we link. The information contained on this website is for educational purposes only. For individual medical care and advice about specific conditions, please contact a doctor.